In AML, higher frequencies of CD34+CD38-, but not CD34+ cells was prognostically adverse[16] and intermediate, versus high, aldehyde dehydrogenase expression correlated with relapse[17,18], supporting the concept that LSC contribute to regrowth. This evidence concerns the gene CD38 and acute myeloid leukemia.